This is the standing evidence sheet for Biohaven (BHVN): the yardsticks BullScope computes from official SEC filings and market prices. It refreshes whenever a new edition of our research is published, and it is impersonal by design, every reader sees the same page. Nothing here is investment advice; it is the evidence, organized.
The price tag: what buyers pay per dollar of profit
The tape: what the stock itself has done
- Last price: $16.49 (end-of-day market data as of the edition date · methodology) · 9% below its 52-week high
- Past 6 months: +71.9% · past 12 months: -4.1%
- Day-to-day temperament: jumpy (annualized volatility 93%)
The road ahead: filed results vs published expectations
| FY2023A | FY2024A | FY2025A | FY2026E | FY2027E | FY2028E | |
|---|---|---|---|---|---|---|
| Net sales ($B) | 0.00 | 0.00 | 0.00 | 0.35 to 0.43 | 0.05 to 0.55 | 0.10 to 0.53 |
| Net sales growth (%) | NM | NM | NM | NM | 25 to 220 | 50 to 360 |
| Operating margin (%) | -inf | -inf | -inf | NM | NM | NM |
| GAAP Diluted EPS ($) | -5.73 | -9.28 | -6.86 | -9.50 to -5.00 | -10.50 to -3.25 | -10.00 to -2.00 |
Columns marked A are actual filed results; E columns are the published consensus ranges the current price is being weighed against.
The four gauges: from the latest edition
BullScope coverage of Biohaven
Read the full report on Biohaven in the BullScope Terminal → It opens with this company loaded.
Edition date: 2026-10-30. This page updates when a new edition is published. Sources: SEC EDGAR filings, Nasdaq prices; computed by BullScope’s published methodology.









